NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy
Intensive, combination chemotherapy for malignant diseases causes a profound immunosuppression, which persists for the whole treatment period and after its completion. Impairment of the NK cells status may increase the risk of severe, disseminated infections and cancer. The aim of the study was the...
المؤلفون الرئيسيون: | Jarosz, M, Hak, L, Wieckiewicz, J, Balcerska, A, Mysliwska, J |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Termedia Publishing House Ltd.
2009
|
مواد مشابهة
-
Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma
حسب: Amandeep Aujla, وآخرون
منشور في: (2019-04-01) -
Evaluation of Bone Mineral Density in Children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin's Lymphoma (NHL): Chemotherapy with/without Radiotherapy
حسب: Ali Ghassemi, وآخرون
منشور في: (2016-06-01) -
Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
حسب: Miguel Enrique Cuéllar Mendoza, وآخرون
منشور في: (2024-02-01) -
Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin’s lymphoma and acute lymphoblastic leukemia
حسب: Betül Sevinir, وآخرون
منشور في: (2011-03-01) -
Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia
حسب: Betül Sevinir, وآخرون
منشور في: (2011-03-01)